The verified answer
As of Aug 2026, DEPLOY verifies Medical Microinstruments (MMI): 1 model, $75.0M raised. 1 source back the record.
CategorySurgical robots
Overview
Medical Microinstruments (MMI) is an Italian medical device company developing the Symani Surgical System, a robotic microsurgery platform that enables surgeons to perform complex microsurgical procedures with enhanced precision. Symani received FDA De Novo authorization in April 2024 and CE mark certification, with the first U.S. clinical use completed in 2025. MMI raised $110M in venture capital to support commercial rollout, with the system manufactured in Pisa, Italy.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
Key facts
Robot
Focus
Technology
Scale
CEO
FDA authorization
Total fundingsee investors →
Product
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Medical Microinstruments (MMI) on the deployment map
View the global mapMedical Microinstruments (MMI) has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for Medical Microinstruments (MMI) on the DEPLOY record yet. Track Medical Microinstruments (MMI) to know the moment the first one is verified.
Current leadership (3)
- Giuseppe Maria Prisco Co-Founder & CEOsince 2015-01-01secondary-verified
- Massimiliano Simi Co-Foundersince 2015-01-01secondary-verified
- Hannah Teichmann Co-Foundersince 2015-01-01secondary-verified
Founders (3)
- Giuseppe Maria Priscocofounderfounded 2015-01-01
- Massimiliano Simicofounderfounded 2015-01-01
- Hannah Teichmanncofounderfounded 2015-01-01
Safety record
No incidents on record for Medical Microinstruments (MMI).
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
Medical Microinstruments (MMI) in third-party press
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- early
- Counterparty risk class
- moderate
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (1)
- Series B2023-01-01
$75M(reported)
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 24, 2026
Added to the verified registry
Sources (1)
Common questions
What is Medical Microinstruments (MMI)?
What does Medical Microinstruments (MMI) make?
Is Medical Microinstruments (MMI) publicly traded?
Who competes with Medical Microinstruments (MMI)?
Who is the CEO of Medical Microinstruments (MMI)?
How can I invest in Medical Microinstruments (MMI)?
Where is Medical Microinstruments (MMI) headquartered?
How much funding has Medical Microinstruments (MMI) raised?
Who owns Medical Microinstruments (MMI)?
Where does Medical Microinstruments (MMI) operate robots?
Is Medical Microinstruments (MMI) a top robotics company?
Is Medical Microinstruments (MMI) safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-05
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-05
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Medical Microinstruments (MMI).Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
In the press
Recent coverage mentioning Medical Microinstruments (MMI) from third-party publications. Automatically surfaced; not part of the verified registry record.
MMI Receives FDA Authorization to Commercialize Symani Surgical System in the U.S.
Medical Microinstruments received FDA De Novo authorization to commercialize its Symani Surgical System in the U.S., building on proven clinical success in Europe.
Medical Microinstruments collects $110M to fund surgical robot rollout
Medical Microinstruments secured $110M in venture capital funding to support the commercial rollout of its Symani robotic microsurgery system globally.
Machine-readable surfaces
- Markdown mirror: /companies/medical-microinstruments.md
- RSS feed: /companies/medical-microinstruments/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/cdec61a2-0b14-4d4f-a9a6-34bff507c286
- Revision history: /companies/medical-microinstruments/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
Video
Reach Precision, enhance Dexterity, gain Control. With 7 to 20x motion scaling and tremor reduction features, the Symani® Surgical System allows surgeons to co
Hear why Professor Alexander Gaggl and Dr. Simon Enzinger decided to begin a microsurgical robotics program at The University Hospital Salzburg (SALK) in Austri
Curious to know why our microsurgical robotic system is named Symani? Watch the video to find out.
Watch Janine’s story to hear about her robotic-assisted breast reconstruction with the Symani Surgical System. Janine opted to pursue autologous breast reconstr
Over the decades, advancements in optic systems improved what surgeons could see. Now, the Symani® Surgical System enhances what surgeons can do.
Jamie Milas, Vice President of Marketing at Medical Microinstruments S.p.A. (MMI), an Italian startup robotics company, discusses their robotic system for micro
‘Connecting Life’ is an important concept for MMI and its employees. It’s our mission to develop, manufacture and market a system that enables surgeons to conne
Reality vs attention
Medical Microinstruments (MMI) draws attention at the 17th percentile but verifies reality at the insufficient-data level among surgical robots.
6-month trend
Analysis
Limited public visibility and press coverage relative to peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 18, 2026